Related Resources
\n- \n
- cancer awareness articles \n
- patient diagnostic resources \n
- laboratory quality standards \n
- cancer diagnostic guidance \n
Test-Specific Disclaimer
\nThis content is for informational purposes only and does not substitute professional medical advice. IHC test interpretation must be performed by qualified pathologists and treating specialists. Please refer to our disclaimer policy.
\n","image":["/images/healthcarentsickcarestore.shop/images/product/ihc-panel-test-gastrointestinal-neoplasm-1.avif"],"sku":"ihc-panel-test-gastrointestinal-neoplasm","brand":{"@type":"Brand","name":"healthcare nt sickcare"},"offers":{"@type":"AggregateOffer","lowPrice":7299,"highPrice":7299,"priceCurrency":"USD","availability":"https://schema.org/InStock","url":"https://healthcarentsickcarestore.shop/products/ihc-panel-test-gastrointestinal-neoplasm","offerCount":1}}
IHC Panel Test for Gastrointestinal Neoplasm
About IHC Panel Test for Gastrointestinal Neoplasm
The IHC Panel Test for Gastrointestinal Neoplasm is a tumour marker identification test performed using immunohistochemistry (IHC), a laboratory technique that detects specific proteins in tissue samples to determine tumour origin. This panel helps classify cancers arising from the stomach, intestine, colon and related digestive organs.
At healthcare nt sickcare in Pune, this test supports oncologists and pathologists in confirming tumour type, guiding treatment planning and predicting disease behaviour. Sample processing is available through our Direct Walk-in Facility, with coordinated sample transport from hospitals and clinics across Pune.
What does this IHC panel analyse?
This panel detects specific gastrointestinal tumour markers to identify cancer origin and proliferation pattern.
Markers Covered in This Panel
CDX2, CK7, CK20, p53 and Ki-67 markers are analysed to distinguish primary gastrointestinal tumours, metastatic lesions and tumour growth activity.
Frequently Asked Questions
This test is advised when biopsy results need confirmation of tumour origin or type in gastrointestinal cancers.
It helps identify whether a tumour is primary gastrointestinal cancer or metastasis from another organ.
No fasting is required as this test is performed on tissue biopsy samples.
Persistent abdominal pain, unexplained weight loss, altered bowel habits or suspected intestinal tumours may require this evaluation.
Related Resources
- cancer awareness articles
- patient diagnostic resources
- laboratory quality standards
- cancer diagnostic guidance
Test-Specific Disclaimer
This content is for informational purposes only and does not substitute professional medical advice. IHC test interpretation must be performed by qualified pathologists and treating specialists. Please refer to our disclaimer policy.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
About IHC Panel Test for Gastrointestinal Neoplasm
The IHC Panel Test for Gastrointestinal Neoplasm is a tumour marker identification test performed using immunohistochemistry (IHC), a laboratory technique that detects specific proteins in tissue samples to determine tumour origin. This panel helps classify cancers arising from the stomach, intestine, colon and related digestive organs.
At healthcare nt sickcare in Pune, this test supports oncologists and pathologists in confirming tumour type, guiding treatment planning and predicting disease behaviour. Sample processing is available through our Direct Walk-in Facility, with coordinated sample transport from hospitals and clinics across Pune.
What does this IHC panel analyse?
This panel detects specific gastrointestinal tumour markers to identify cancer origin and proliferation pattern.
Markers Covered in This Panel
CDX2, CK7, CK20, p53 and Ki-67 markers are analysed to distinguish primary gastrointestinal tumours, metastatic lesions and tumour growth activity.
Frequently Asked Questions
This test is advised when biopsy results need confirmation of tumour origin or type in gastrointestinal cancers.
It helps identify whether a tumour is primary gastrointestinal cancer or metastasis from another organ.
No fasting is required as this test is performed on tissue biopsy samples.
Persistent abdominal pain, unexplained weight loss, altered bowel habits or suspected intestinal tumours may require this evaluation.
Related Resources
- cancer awareness articles
- patient diagnostic resources
- laboratory quality standards
- cancer diagnostic guidance
Test-Specific Disclaimer
This content is for informational purposes only and does not substitute professional medical advice. IHC test interpretation must be performed by qualified pathologists and treating specialists. Please refer to our disclaimer policy.
